Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04155190
Title An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors PellePharm, Inc.

basal cell carcinoma


Patidegib topical gel

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Axiom Research, LLC Apple Valley California 92307 United States Details
Axiom Research, LLC Colton California 92324 United States Details
Center for Dermatology Clinical Research, Inc. Fremont California 94538 United States Details
Dermatology Research Associates Los Angeles California 90045 United States Details
The Dermatology Center of Newport Newport Beach California 92660 United States Details
Palm Beach Dermatology Research Delray Beach Florida 33484 United States Details
Leavitt Medical Associates of Florida Ormond Beach Florida 32174 United States Details
PellePharm Investigative Site Saint Augustine Florida 32080 United States Details
The Indiana Clinical Trials Center Plainfield Indiana 46168 United States Details
Grekin Skin Institute Warren Michigan 48088 United States Details
PellePharm Investigative Site Henderson Nevada 89052 United States Details
Skin Laser and Surgery Specialists of NY&NJ Hackensack New Jersey 07601 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
University of Utah Murray Utah 84107 United States Details
*Shaded cells indicate that there was no data available from for the field